Baptist MD Anderson opens new stem cell transplant unit in Jacksonville

Baptist MD Anderson Cancer Center has opened a new Cellular Therapy and Stem Cell Transplant Unit at Baptist Medical Center in Jacksonville, expanding the region's capacity to deliver advanced cancer treatments. The facility was designed with direct input from cancer patients and their families, according to Baptist Health.

The new unit is dedicated to cellular therapy and stem cell transplantation, two cutting-edge treatment modalities for blood cancers and other malignancies. Baptist MD Anderson is the Jacksonville-area partnership between Baptist Health and Houston's MD Anderson Cancer Center, one of the nation's top-ranked cancer institutions.

What's happening

The Cellular Therapy and Stem Cell Transplant Unit represents an expansion of Baptist MD Anderson's specialized treatment capabilities on the Baptist Medical Center campus. The facility is purpose-built for patients undergoing stem cell transplants—a complex, multi-week process that requires isolation and intensive monitoring to prevent infection while a patient's immune system regenerates.

Baptist Health emphasized that the unit's design centered on the needs of patients and families who face extended inpatient stays during transplant procedures. The patient-focused design approach reflects the reality that stem cell transplant recipients often spend three to six weeks or more in the hospital during the acute phase of treatment, requiring private rooms, strict infection control, and spaces for family members who serve as caregivers.

The new unit is part of Baptist MD Anderson Cancer Center, which operates as a partnership between Jacksonville-based Baptist Health and the University of Texas MD Anderson Cancer Center. The collaboration brings MD Anderson protocols, clinical trials, and specialist expertise to Northeast Florida patients who might otherwise need to travel to Houston or other major cancer centers for these treatments.

Expanding access to advanced cancer care in Northeast Florida

The opening addresses a gap in regional healthcare infrastructure. Stem cell transplants and cellular therapies—including CAR T-cell therapy, which genetically engineers a patient's immune cells to attack cancer—require specialized facilities, trained nursing staff, and on-site physician expertise that only a handful of hospitals in Florida can provide.

Before partnerships like Baptist MD Anderson established local programs, many Northeast Florida patients facing blood cancers such as leukemia, lymphoma, and multiple myeloma had to relocate to Tampa, Gainesville, Miami, or out of state for transplant care. The logistical and financial burden on families—temporary housing, time away from work, separation from support networks—often compounded the stress of a life-threatening diagnosis.

By housing these services locally, the unit allows patients to remain closer to home during treatment and recovery. Family members can more easily visit and participate in care, which is particularly important given that stem cell transplant patients are often isolated due to compromised immune systems and cannot leave the hospital for weeks at a time.

The facility also positions Baptist Health to recruit and retain specialized oncology nurses, transplant coordinators, and physicians in Jacksonville. Stem cell transplant programs require multidisciplinary teams including hematologist-oncologists with transplant fellowship training, infectious disease specialists, pharmacists experienced in chemotherapy and immunosuppression, and nurses trained in bone marrow transplant protocols. The presence of such a program contributes to the depth of the region's medical workforce.

How patient input shaped the design

Baptist Health's emphasis on patient-centered design reflects a broader shift in healthcare facility planning, particularly for units where patients spend extended periods. The source material notes that cancer patients and their families were at the forefront of the design process, though specific design features resulting from that input were not detailed in the available excerpt.

In stem cell transplant units nationally, patient-driven design priorities typically include private rooms with space for a family member to sleep overnight, windows with natural light, air filtration systems that reduce infection risk while allowing patients to feel less isolated, and proximity to nursing stations for rapid response. Family input often leads to amenities such as nearby kitchenettes, comfortable waiting areas, and private consultation spaces where physicians can discuss complex treatment decisions away from the bedside.

The design process matters because the physical environment can significantly affect patient outcomes and quality of life during transplant. Studies in healthcare design have linked natural light, noise reduction, and family presence to improved patient satisfaction and, in some cases, shorter hospital stays and fewer complications. For patients enduring the physical and emotional toll of high-dose chemotherapy followed by immune system reconstitution, environmental factors can influence their ability to cope and recover.

Incorporating patient voices into facility planning also helps hospitals anticipate practical needs that clinical staff might overlook—such as adequate storage for personal items during a month-long stay, visual privacy without complete isolation, or spaces where pediatric patients can continue schoolwork or play during treatment.

Impact on the local cancer-care landscape

The new unit strengthens Baptist MD Anderson's position in a competitive regional oncology market. In Northeast Florida, cancer patients have multiple options for care, including UF Health's academic medical center in Jacksonville, Mayo Clinic's Florida campus, and Ascension St. Vincent's. Each system has invested in oncology services as the region's aging population drives demand.

Baptist MD Anderson's affiliation with Houston's MD Anderson—consistently ranked among the top two cancer hospitals in the United States by U. S. News & World Report—gives the Jacksonville program access to clinical trial networks and subspecialized expertise. For patients with rare cancers or those who have exhausted standard therapies, access to MD Anderson protocols without leaving Florida can be a decisive factor in choosing where to seek care.

The expansion also has economic development implications. Advanced medical facilities serve as anchors for related businesses—medical equipment suppliers, outpatient pharmacies, temporary housing for patient families, and laboratory services. Hospitals with specialized transplant programs often attract referring physicians and support continued growth of academic and research activity.

For commercial real estate and healthcare-sector employers in Jacksonville, the trajectory of Baptist Health and other hospital systems signals sustained investment in the city's medical district along San Marco and Riverside, as well as the Southside campuses. Healthcare remains one of Duval County's largest employment sectors, and capital investments in specialized clinical programs like transplant services indicate long-term institutional commitment to the market.

What the expansion means for patients and families

For the estimated thousands of people diagnosed with blood cancers in Northeast Florida each year, the presence of a local stem cell transplant program can change the calculus of treatment. Transplant is often curative for diseases like acute leukemia and certain lymphomas, but the decision to pursue it involves weighing not only medical risks but also the logistics of extended time away from home.

The ability to receive transplant care locally allows patients to maintain closer ties to their community, primary care physicians, and established support systems. It also makes it easier for local oncologists to refer appropriate candidates for transplant earlier in the disease course, when outcomes are often better.

Family caregivers—who play a critical role in post-transplant recovery, administering medications, monitoring for complications, and providing emotional support—face fewer disruptions to their own lives when treatment occurs in Jacksonville rather than requiring temporary relocation. This is especially significant for families with children still in school, elderly relatives needing care, or caregivers who cannot afford to leave jobs for extended periods.

From a public health perspective, expanding access to advanced cancer therapies locally can help reduce disparities in who receives potentially life-saving treatments. Patients with fewer financial resources or less flexible work arrangements are more likely to pursue transplant if it is available close to home.

What happens next

The Cellular Therapy and Stem Cell Transplant Unit is now operational and accepting patients. Baptist MD Anderson will likely continue to expand its clinical trial portfolio and recruit additional transplant and cellular therapy specialists as the program matures.

Patients considering stem cell transplant typically undergo evaluation by a transplant team to determine candidacy based on disease type, stage, overall health, and availability of a suitable donor. Those evaluations can now be conducted at Baptist MD Anderson without requiring initial consultations in Houston or other out-of-area centers.

The opening of this unit aligns with broader growth in Jacksonville's medical infrastructure, as hospital systems across Northeast Florida invest in specialized services to serve a rapidly growing and aging population. As the region continues to attract retirees and families relocating from higher-cost markets, demand for advanced healthcare—particularly oncology and cardiovascular services—is expected to climb, driving further capital investment in hospital facilities and physician recruitment.